glp 1 side effects blindness Ozempic LEAD TO BLINDNESS?! There’s been a lot of

Human evidence is mixed, with some studies showing no increased risk and others showing a small increase

Argun-Kurum G, Kaya-Dagistanli F, Ozturk M

Another concern is the rising use of non-FDA-approved, compounded versions of semaglutideoften purchased online due to shortages of name-brand drugs

The push for a standalone MDL follows research from Harvard and JAMA Ophthalmology indicating that GLP-1 drugs may increase the risk of NAION up to sevenfold

Morgan Stanley Research has forecast that China and Brazil could see rapid expansion in GLP-1 uptake as generic competition reduces prices substantially

Panagiotopoulou, and M